http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8703169-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5e07888f923b7443f3b8eb913614893
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
filingDate 1987-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_337b161b90605dd0162b9502046891cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4048addc591bacac42e92c3b48aed271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada9c8003c879cb2e379db1af15b7e6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db24c75652a8c8df78d72f9304cc76bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0021c288bb9df0910c44d6546838dc93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc8a64582dffde71be6284d118e9c0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9cee53e1c73dcab2338ec548f3dfb8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5952a9a0b017e49553d0f8cb0c869395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a7dbd044a22f4dcd94b04b1eb71cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b688807b1ba43b6c48047c355d45281
publicationDate 1987-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8703169-D0
titleOfInvention 1- (4-AMINOPHENYL) -4-METHYL-7,8-METHYLENEDIOXY-3,4-DIHYDRO-5H-2,3-BENZODIAZEPINE, ACID ADDITION SALTS THEREOF AND PROCESS FOR PREPARING SAME
abstract The invention relates to new 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzo diazepi ne of formula (1), optically active isomers and acid addition salts thereof as well as to pharmaceutical compositions containing these compounds. <IMAGE> (I) The new compounds of formula (I) can be prepared by reducing 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine of formula (II) with an inorganic or organic-inorganic and/or complex metal hydride and, if desired, separating the optically active forms of the compound of formula (I) thus-obtained and, if desired, converting the base or bases into acid addition salts or converting the salts into the free bases(s). <IMAGE> (II) The new compound of formula (I) possesses significant central nervous effects and can advantageously be used in the therapy.
priorityDate 1986-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3539

Total number of triples: 30.